Some Of The Top Penny Stocks To Watch On Monday
Penny stocks are perhaps some of the most sought after stocks in the market for those looking to make quick money. The reason behind that lies in the fact that these cheap stocks allow investors to make a substantial return even if the stock moves upward slightly.
However, it’s not as easy as it seems. Sure, it’s as easy as hitting the buy or sell button in your brokerage account. But the process to find the best penny stocks to buy takes time. An investor needs to conduct research thoroughly.
Pay attention to things like penny stock news, a company’s corporate filings, and even market chatter. We’ve seen countless breakouts after rumors buzz about a certain company. But it’s important to keep in mind that rumors are simply speculation based on little if any concrete information. Regardless of the fact, rumors can become a real catalyst for breakouts.
- Penny Stocks To Buy Or Avoid? All Just Made New December Highs
- 2 Penny Stocks With High Hopes For A Reversal
- Penny Stocks On Robinhood To Watch If You Work A Day Job
We saw it earlier this year when “people close to the situation” hinted that Google might buy Fitbit. It ended up becoming true and traders profited handsomely from the move. At the end of the day, the best way of researching is by following the market closely. Keeping track of the latest movements in penny stocks is key. Here is a look at a few penny stocks to watch this week.
Penny Stocks to Trade #1 Vistagen Therapeutics (VTGN)
Biotech company Vistagen Therapeutics Inc (VTGN Stock Report) saw a big move this month. On December 10, it emerged that its social anxiety disorder product PH94B was given the coveted Fast Track designation by the FDA. Based on this, VistaGen is preparing PH94B for Phase 3 development.
It goes without saying that it is a highly significant development for the company and the market realized that as well. VTGN stock rallied by as much as 75% over the course of the past week. On top of that, shares have rallied dramatically since mid-November.
Following a huge blow to the company after reporting missing its primary endpoints on a depression drug, VTGN began to reverse course. At the time, shares traded as low as $0.29. Obviously, since that time, the stock has bounced back by as much as 217%. Will this fast-track designation continue to fuel shares through the new year?
Penny Stocks to Trade #2 Camber Energy Inc. (CEI)
One of the popular low float penny stocks to watch this month was Camber Energy (CEI Stock Report). The most important aspect to pay attention to here is that CEI hasn’t reported anything new. In fact, late last week the company came out and stated that fact:
“Camber confirms that although it is customarily involved in ongoing discussions with multiple parties regarding potential transactions, it is not currently aware of any material undisclosed information which is binding on the Company, that may be contributing to the recent increase in trading volume and increase in market price.”Camber Press Release From December 11, 2019
What is true, however, is that the share structure of CEI stock lent itself to big moves on strong momentum. Over the last 5 trading days, its stock has seen more than 71 million shares exchange hands. Whether you’re a firm believer in the company or just watching for concrete info to come out, CEI stock has been one of the most talked-about penny stocks in December. Not only has it climbed by more than 170% month-to-date but it’s also seen highs of $3.10 in December as well.
Penny Stocks To Trade #3 Cyclerion Therapeutics Inc. (CYCN)
In a similar fashion to VTGN, Cyclerion Therapeutics (CYCN Stock Report) has worked to bounce back from a big hit in October. At the time, CYCN stock plunged after the company reported that it missed primary endpoints in a study of its diabetic therapy and went as far as discontinuing the development of the drug. That saw shares dive from over $11 to as low as $1.69 in November.
- 3 Penny Stocks To Buy Or Sell After Hitting New Highs
- Penny Stocks On Robinhood To Watch On Monday
- Money Making Penny Stocks: 1 Up 780% In 7 Days
So what happened recently that has investors excited about this company again? Cyclerion recently presented at the Evercore ISI HealthCONx Conference earlier this month. There wasn’t much of a response in the market until this week. On Monday, shares rallied to highs of $2.43 just before the lunch hour. This marked a move of more than 40% since hitting 2019 lows in November. There haven’t been any new updates that would indicate such a move.
But it’s important to note that the company has seen stronger insider buying this quarter. Chief Innovation Officer Andres Busch, President Mark Currie, CEO Peter Hecht, & CFO William Huyettt exercised options to up their stake in the company. Busch went further to purchase another 125,000 shares in the market at an average price of $1.82. If you like to get full details like this, don’t forget we offer access to all of this information for free on the stock profile pages on PennyStocks.com. You can check out Cyclerion’s here.
Penny Stocks To Trade #4 Trillium Therapeutics (TRIL)
One of the top-performing penny stocks this quarter was Trillium Therapeutics (TRIL Stock Report). Though TRIL stock consolidated early on to lows of $0.2405, the general trend has been consistent. But what has attention on the company this month is the last 4 days of trading. The interesting part, similar to CEI, is that there have been no developments to speak of. In fact, there hasn’t been anything from the company (including filings) since November.
The company itself has focused on restructuring and near term opportunities with its intravenous TTI-621 therapy. Recent market chatter suggests people are looking for results from the company’s current progress with TTI-621.
[Read More] Penny Stocks & Popular Technical Indicators For Increasing Profits
There’s also a likely focus on what the next move will be as far as “exploring a number of strategic alternatives to maximize shareholder value.” In any case, TRIL stock has climbed by 86% since December 2.